Defining a threshold for safe surgical management of vena cava thrombus in renal cell carcinoma patients: evidence from German total population data with 3,700 cases from 2006 to 2020 - Summary - MDSpire
Advertisement
Defining a threshold for safe surgical management of vena cava thrombus in renal cell carcinoma patients: evidence from German total population data with 3,700 cases from 2006 to 2020
To examine treatment patterns for renal cell carcinoma tumor thrombus (RCCTT) and assess specific factors impacting in-hospital mortality, such as surgical approach and hospital caseload.
Key Findings:
Stable incidence of renal cancer in Germany from 2006 to 2019, with a declining age-standardized ratio.
Surgical management of RCCTT showed stable annual case numbers and an increase in transperitoneal approach usage.
Overall blood transfusion rates decreased from 77.8% to 66.1%, while LOS decreased from 18.2 to 15.6 days.
Total in-hospital mortality was 5.8%, with lower mortality associated with higher annual hospital caseloads.
Interpretation:
The study highlights the importance of surgical experience and hospital volume in managing RCCTT, indicating that higher caseloads correlate with better outcomes.
Limitations:
Lack of official guidelines for surgical management of RCCTT, which may impact treatment consistency and patient outcomes.
Variability in mortality rates over the years without a clear trend, indicating the need for further investigation.
Conclusion:
The findings suggest a need for established guidelines and further research to optimize surgical management of RCCTT, particularly in high-volume centers, emphasizing the correlation between surgical experience and patient outcomes.
by Thomas Martin, Johannes Huber, Rainer Koch, Marius Butea-Bocu, Lennard Haak, Luka Flegar, Matthias Giese, Fabian Kormann, Cem Aksoy, Aristeidis Zacharis, Christer Groeben
